Axolot Solutions Holding AB (AXOLOT) AI Stock Analysis

• Market Cap: €93.98M
• Dividend Yield: N/A
• Average Volume (3M): 426.27K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.69
• Revenue Growth: -27.29%
• EPS Growth: 72.72%
• Country: SE
• Employees: 3
• Sector: Industrials
• Sector Strength: 72
• Industry: Waste Management
• EPS (TTM): >-0.01
• Shares Outstanding: 295,534,240
• 10 Day Avg. Volume: 426,168
• 30 Day Avg. Volume: 426,274
• PEG Ratio: 0.10
• Price to Book (P/B): 0.74
• Price to Sales (P/S): 18.13
• P/FCF Ratio: -4.75
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: ―

Axolot Solutions Holding AB's overall stock score is low, primarily due to its financial struggles, including declining revenues and cash flow issues. Despite a strong equity position, the company's lack of profitability and negative valuation metrics weigh heavily on its performance. Technical indicators suggest a neutral market stance, with no clear upward or downward momentum.

Axolot Solutions Holding AB Business Overview & Revenue Model

Company Description

Axolot Solutions Holding AB (publ), an environmental technology company, provides systems for industrial water purification under the AxoPur and AxoPlus names in Sweden. The company offers solutions for industries and waste owners, including effluent purification, waste minimization, process water cleaning for recirculation, energy recovery via water recirculation or floc burning, and material recovery via floc reprocessing. The company was founded in 2014 and is headquartered in Helsingborg, Sweden.

How the Company Makes Money

Axolot Solutions Holding AB generates revenue primarily through the sale and implementation of its water treatment systems. The company's key revenue streams include the direct sale of its proprietary water purification equipment and related services such as installation, maintenance, and support. Axolot may also engage in leasing arrangements for its technology, providing a recurring revenue stream. Additionally, the company could partner with industrial clients or governmental bodies in need of sustainable water treatment solutions, which can lead to long-term contracts and collaborations. By focusing on industries with significant water treatment needs, Axolot taps into a growing market driven by environmental regulations and the increasing need for sustainable industrial processes.

Axolot Solutions Holding AB Financial Statement Overview

Summary

Axolot Solutions Holding AB faces significant financial challenges with declining revenues and profitability issues. On the positive side, the company maintains a strong equity position with no debt, offering financial resilience. However, the negative cash flows and persistent losses put pressure on future operations and growth.

Income Statement

The company has faced declining revenues over the past years, with a consistent negative net income indicating ongoing losses. Gross profit margin is relatively healthy at 97.65% for the latest period, but the significant negative EBIT and EBITDA margins reflect operational inefficiencies and challenges in covering operating expenses.

Balance Sheet

The balance sheet shows a strong equity position with no debt, as evident by a debt-to-equity ratio of 0. The company's equity ratio is remarkably high at 98.27%, suggesting financial stability. However, the persistent negative net income affects the return on equity, which remains negative.

Cash Flow

The company has been experiencing negative operating and free cash flows, indicating cash burn. Yet, the absence of debt financing has been a positive aspect. The free cash flow growth rate is negative, reflecting a decrease in cash-generating capacity.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	8.90M	2.98M	1.65M	2.04M	2.96M	3.98M
Gross Profit	1.70M	2.91M	1.65M	1.65M	2.08M	2.36M
EBITDA	-6.81M	-17.53M	-13.65M	-15.65M	-14.78M	-16.43M
Net Income	-7.86M	-18.01M	-16.41M	-20.41M	-18.30M	-19.86M
Balance Sheet
Total Assets	83.21M	73.96M	29.51M	26.98M	23.95M	44.55M
Cash, Cash Equivalents and Short-Term Investments	14.67M	7.28M	16.97M	17.03M	12.87M	23.47M
Total Debt	0.00	0.00	922.00K	0.00	0.00	0.00
Total Liabilities	4.00M	1.27M	1.29M	2.37M	2.50M	4.76M
Stockholders Equity	79.20M	72.68M	21.72M	24.61M	21.45M	39.78M
Cash Flow
Free Cash Flow	-12.32M	-11.37M	-14.44M	-17.42M	-13.61M	-16.66M
Operating Cash Flow	-6.94M	-6.12M	-12.41M	-14.16M	-12.50M	-15.39M
Investing Cash Flow	-10.54M	-10.25M	-2.03M	-3.26M	-1.11M	-1.26M
Financing Cash Flow	17.07M	8.79M	14.38M	21.69M	3.00M	19.94M

Axolot Solutions Holding AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.32
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AXOLOT, the sentiment is Negative. The current price of 0.32 is below the 20-day moving average (MA) of 0.35, below the 50-day MA of 0.38, and below the 200-day MA of 0.44, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 31.54 is Neutral, neither overbought nor oversold. The STOCH value of 25.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:AXOLOT.

Axolot Solutions Holding AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
LEVEL	54 Neutral	€115.60M	-10.30	-1.58%	―	2.70%	85.94%
CIRCHE	46 Neutral	€53.07M	24.40	-15.79%	―	―	―
AXOLOT	43 Neutral	€93.98M	-9.58	-17.60%	―	-27.29%	72.72%
SAXG	42 Neutral	€70.26M	―	-14.54%	―	-17.38%	96.53%
TRIBO.B	38 Underperform	€34.55M	―	-6.99%	―	7.63%	91.37%
BIOEX	32 Underperform	kr98.07M	―	-111.91%	―	-27.18%	33.32%